The Patent Finder

Formulations of Viloxazine

Supernus Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 61/596,458, filed Feb 8, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,358,204Formulations of Viloxazine
In force
 · High confidence
Supernus Pharmaceuticals, Inc.In force
High confidence
US 9,603,853Formulations of Viloxazine
In force
 · High confidence
Supernus Pharmaceuticals, Inc.In force
High confidence
US 10,265,319Formulations of Viloxazine
In force
 · High confidence
Supernus Pharmaceuticals, Inc.In force
High confidence
US 9,662,338Formulations of Viloxazine
In force
 · High confidence
Supernus Pharmaceuticals, Inc.In force
High confidence
Application 16/297,194Formulations of Viloxazine
Pending
Not granted
Supernus Pharmaceuticals, Inc.PendingNot granted
Application 18/232,716Formulations of Viloxazine
Abandoned
Abandoned Jul 10, 2025
Supernus Pharmaceuticals, Inc.AbandonedAbandoned Jul 10, 2025
Application 19/093,755Formulations of Viloxazine
Pending
Not granted
Supernus Pharmaceuticals, Inc.PendingNot granted
Application 19/171,852Formulations of Viloxazine
Pending
Not granted
Supernus Pharmaceuticals, Inc.PendingNot granted
Application 19/306,464Formulations of Viloxazine
Pending
Not granted
Supernus Pharmaceuticals, Inc.PendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Supernus Pharmaceuticals, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited